PHP
ILMN icon

Parkman Healthcare Partners’s Illumina ILMN Stock Holding History

Parkman Healthcare Partners’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6M Buy
+110,370
New +$14.5M 1.4% 23

Other funds holding ILMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's ILMN Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in Illumina (ILMN) in Q1 2026: 110,370 shares worth $13.6M. The stake represents 1.4% of the portfolio and ranks #23 among its holdings.

845 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • Parkman Healthcare Partners held 110,370 shares of Illumina worth $13.6M as of Q1 2026.
  • Illumina was a new Parkman Healthcare Partners position in Q1 2026.
  • Illumina made up 1.4% of Parkman Healthcare Partners's portfolio in Q1 2026, its #23 holding.
  • 845 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.